129 related articles for article (PubMed ID: 1360329)
1. Dual colour flow cytometry of p53 and c-erbB-2 expression related to DNA aneuploidy in primary and metastatic breast cancer.
Clark JS; George WD; Campbell AM
Cancer Lett; 1992 Oct; 66(3):193-200. PubMed ID: 1360329
[TBL] [Abstract][Full Text] [Related]
2. c-erbB-2 oncogene related to p53 expression, cell proliferation and prognosis in breast cancer.
Lipponen HJ; Aaltomaa S; Syrjänen S; Syrjänen K
Anticancer Res; 1993; 13(4):1147-52. PubMed ID: 8102517
[TBL] [Abstract][Full Text] [Related]
3. Internal mammary nodal status is a more reliable prognostic factor than DNA ploidy and c-erb B-2 expression in patients with breast cancer.
Noguchi M; Koyasaki N; Ohta N; Kitagawa H; Earashi M; Thomas M; Miyazaki I; Mizukami Y
Arch Surg; 1993 Feb; 128(2):242-6. PubMed ID: 8094282
[TBL] [Abstract][Full Text] [Related]
4. Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients.
Isola J; Visakorpi T; Holli K; Kallioniemi OP
J Natl Cancer Inst; 1992 Jul; 84(14):1109-14. PubMed ID: 1352359
[TBL] [Abstract][Full Text] [Related]
5. Significance of c-erbB-2 amplification and DNA aneuploidy. Analysis in 78 patients with node-negative breast cancer.
Babiak J; Hugh J; Poppema S
Cancer; 1992 Aug; 70(4):770-6. PubMed ID: 1353701
[TBL] [Abstract][Full Text] [Related]
6. Multiparameter flow cytometry for simultaneous assessment of p53 protein expression and cellular DNA content in oral squamous cell carcinomas: evidence for the development of aneuploid clones from p53-deficient diploid progenitor cells.
Hemmer J; Polackova J
Int J Oncol; 2000 Nov; 17(5):933-7. PubMed ID: 11029495
[TBL] [Abstract][Full Text] [Related]
7. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A
Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041
[TBL] [Abstract][Full Text] [Related]
8. c-erbB-2/c-erbA co-amplification indicative of lymph node metastasis, and c-myc amplification of high tumour grade, in human breast carcinoma.
Tavassoli M; Quirke P; Farzaneh F; Lock NJ; Mayne LV; Kirkham N
Br J Cancer; 1989 Oct; 60(4):505-10. PubMed ID: 2572268
[TBL] [Abstract][Full Text] [Related]
9. Amplification of ERBB-2 (HER-2/NEU) oncogene in different neoplasms of patients from USSR.
Knyazev PG; Imyanitov EN; Chernitca OI; Nikiforova IF; Hanson KP
Oncology; 1992; 49(2):162-5. PubMed ID: 1349430
[TBL] [Abstract][Full Text] [Related]
10. [Expression of adhesive molecule CD44v6 and p53 gene in breast cancer tissues and its relation with DNA ploidy].
Zuo WS; Wei L; Wang XW; Wang YS; Yu ZY
Ai Zheng; 2004 Nov; 23(11 Suppl):1418-22. PubMed ID: 15566648
[TBL] [Abstract][Full Text] [Related]
11. Mutant p53, EGF receptor and c-erbB-2 expression in human breast cancer.
Horak E; Smith K; Bromley L; LeJeune S; Greenall M; Lane D; Harris AL
Oncogene; 1991 Dec; 6(12):2277-84. PubMed ID: 1685017
[TBL] [Abstract][Full Text] [Related]
12. c-erbB-3 protein expression in ovarian tumours.
Simpson BJ; Weatherill J; Miller EP; Lessells AM; Langdon SP; Miller WR
Br J Cancer; 1995 Apr; 71(4):758-62. PubMed ID: 7710941
[TBL] [Abstract][Full Text] [Related]
13. p53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer.
Barbareschi M; Leonardi E; Mauri FA; Serio G; Dalla Palma P
Am J Clin Pathol; 1992 Oct; 98(4):408-18. PubMed ID: 1357956
[TBL] [Abstract][Full Text] [Related]
14. Expression of the c-erbB-2 proto-oncogene product and nuclear DNA content in benign and malignant human breast parenchyma.
Schimmelpenning H; Eriksson ET; Falkmer UG; Azavedo E; Svane G; Auer GU
Virchows Arch A Pathol Anat Histopathol; 1992; 420(5):433-40. PubMed ID: 1350695
[TBL] [Abstract][Full Text] [Related]
15. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for prediction of poor short term prognosis in breast cancer.
Eissa S; Khalifa A; el-Gharib A; Salah N; Mohamed MK
Anticancer Res; 1997; 17(2B):1417-23. PubMed ID: 9137508
[TBL] [Abstract][Full Text] [Related]
16. Multivariate analysis of bcl-2, apoptosis, P53 and HER-2/neu in breast cancer: a short-term follow-up.
el-Ahmady O; el-Salahy E; Mahmoud M; Wahab MA; Eissa S; Khalifa A
Anticancer Res; 2002; 22(4):2493-9. PubMed ID: 12174951
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous analysis of c-erbB-2 expression and DNA content in breast cancer using flow cytometry.
Stål O; Sullivan S; Sun XF; Wingren S; Nordenskjöld B
Cytometry; 1994 Jun; 16(2):160-8. PubMed ID: 7924685
[TBL] [Abstract][Full Text] [Related]
18. Detection of c-erbB-2 oncoprotein expression in breast tissue by multiparameter flow cytometry.
Li BD; Bauer KD; Carney WP; Duda RB
J Surg Res; 1993 Mar; 54(3):179-88. PubMed ID: 7682635
[TBL] [Abstract][Full Text] [Related]
19. Correlations among p53, Her-2/neu, and ras overexpression and aneuploidy by multiparameter flow cytometry in human breast cancer: evidence for a common phenotypic evolutionary pattern in infiltrating ductal carcinomas.
Smith CA; Pollice AA; Gu LP; Brown KA; Singh SG; Janocko LE; Johnson R; Julian T; Hyams D; Wolmark N; Sweeney L; Silverman JF; Shackney SE
Clin Cancer Res; 2000 Jan; 6(1):112-26. PubMed ID: 10656439
[TBL] [Abstract][Full Text] [Related]
20. Uterine papillary serous adenocarcinoma. A 10-case study of p53 and c-erbB-2 expression and DNA content.
Prat J; Oliva E; Lerma E; Vaquero M; Matías-Guiu X
Cancer; 1994 Sep; 74(6):1778-83. PubMed ID: 7915964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
